Study Protocol
Accepted on 06 Oct 2025
The efficacy, safety, and PK/PDpharmacokinetics/pharmacodynamics of telitacicept following efgartigimod in generalized myasthenia gravis: protocol of a randomized controlled trial
in Multiple Sclerosis and Neuroimmunology